Debt to Equity Ratio Chart

View Debt to Equity Ratio for STAA.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Debt to Equity Ratio Chart
Start Trial

Historical Debt to Equity Ratio Data

View and export this data back to 1998. Start Trial.
Date Value
June 30, 2026 0.0984
March 31, 2026 0.1058
December 31, 2025 0.1114
September 30, 2025 0.1106
June 30, 2025 0.1204
March 31, 2025 0.1048
December 31, 2024 0.0975
September 30, 2024 0.0934
June 30, 2024 0.0887
March 31, 2024 0.0909
December 31, 2023 0.0928
September 30, 2023 0.0948
June 30, 2023 0.0919
March 31, 2023 0.0941
December 31, 2022 0.0923
September 30, 2022 0.0935
June 30, 2022 0.1037
March 31, 2022 0.1153
December 31, 2021 0.124
September 30, 2021 0.0941
June 30, 2021 0.0546
March 31, 2021 0.0473
December 31, 2020 0.0548
September 30, 2020 0.0517
June 30, 2020 0.0435
Date Value
March 31, 2020 0.0494
December 31, 2019 0.0597
September 30, 2019 0.0693
June 30, 2019 0.0813
March 31, 2019 0.0863
December 31, 2018 0.0403
September 30, 2018 0.048
June 30, 2018 0.1367
March 31, 2018 0.1689
December 31, 2017 0.1455
September 30, 2017 0.161
June 30, 2017 0.1786
March 31, 2017 0.1946
December 31, 2016 0.1799
September 30, 2016 0.1859
June 30, 2016 0.1736
March 31, 2016 0.129
December 31, 2015 0.1216
September 30, 2015 0.1196
June 30, 2015 0.1183
March 31, 2015 0.1357
December 31, 2014 0.1352
September 30, 2014 0.1367
June 30, 2014 0.1428
March 31, 2014 0.1256

Debt to Equity Ratio Definition

The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.

Read full definition.

Debt to Equity Ratio Range, Past 5 Years

View Debt to Equity Ratio Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Debt to Equity Ratio Benchmarks

View Debt to Equity Ratio Benchmarks
Start Trial
Intuitive Surgical, Inc. 0.00
Enovis Corp. 0.9269
Stryker Corp. 0.6439
Zimmer Biomet Holdings, Inc. 0.5924
Edwards Lifesciences Corp. 0.0663